Podchaser Logo
Home
Pharma UnlimitedEpisode from the podcastPharma Unlimited
Can ethics keep pace with pharma innovation?

Can ethics keep pace with pharma innovation?

Released Monday, 17th January 2022
Good episode? Give it some love!
Can ethics keep pace with pharma innovation?

Can ethics keep pace with pharma innovation?

Can ethics keep pace with pharma innovation?

Can ethics keep pace with pharma innovation?

Monday, 17th January 2022
Good episode? Give it some love!
Rate Episode
About
InsightsPodchaser Pro
Reviews
Credits
Lists
Transcript

In this episode, Klaus Moosmayer, Chief Ethics, Risk and Compliance Officer at Novartis speaks with Pharma Unlimited podcast host, Bertrand Bodson, about ethics and the ability for them to keep up with innovation in the pharma industry.

Show More
Rate
Get this podcast via API

From The Podcast

Pharma Unlimited

1
Welcome to Pharma Unlimited, by Wolters Kluwer. Join host Bertrand Bodson as we go under the microscope to examine some of the biggest issues facing the pharma sector. What will the arrival of Big Tech mean for innovation, risk, and regulation? How will the industry develop new treatments in a post-pandemic world? This five-part series will feature some of the leading lights in life sciences and technology and explore some of the biggest questions facing the pharma industry.

Join Podchaser to...

  • Rate podcasts and episodes
  • Follow podcasts and creators
  • Create podcast and episode lists
  • & much more

Episode Tags

Do you host or manage this podcast?
Claim and edit this page to your liking.
,

Unlock more with Podchaser Pro

  • Audience Insights
  • Contact Information
  • Demographics
  • Charts
  • Sponsor History
  • and More!
Pro Features
Podchaser Logo

Podchaser is the ultimate destination for podcast data, search, and discovery. Learn More